1. Cheng, Cheng, Zhu, Guangjie, Wang, Kaijian, Yu, Chenjie, Gao, Xia. 2024. Deletion of Luzp2 Does Not Cause Hearing Loss in Mice. In Neuroscience bulletin, 40, 1519-1528. doi:10.1007/s12264-024-01202-5. https://pubmed.ncbi.nlm.nih.gov/38589712/
2. Li, Yong, Deng, Gang, Qi, Yangzhi, Liu, Baohui, Chen, Qianxue. 2020. Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma. In BioMed research international, 2020, 9716720. doi:10.1155/2020/9716720. https://pubmed.ncbi.nlm.nih.gov/32695826/
3. Stepanov, Vadim, Vagaitseva, Kseniya, Bocharova, Anna, Minaycheva, Larisa, Makeeva, Oksana. 2018. Analysis of Association of Genetic Markers in the LUZP2 and FBXO40 Genes with the Normal Variability in Cognitive Performance in the Elderly. In International journal of Alzheimer's disease, 2018, 2686045. doi:10.1155/2018/2686045. https://pubmed.ncbi.nlm.nih.gov/29850221/
4. Feng, Dechao, Zhu, Weizhen, Shi, Xu, Wei, Qiang, Yang, Lu. 2022. Leucine zipper protein 2 serves as a prognostic biomarker for prostate cancer correlating with immune infiltration and epigenetic regulation. In Heliyon, 8, e10750. doi:10.1016/j.heliyon.2022.e10750. https://pubmed.ncbi.nlm.nih.gov/36217461/
5. Li, Jie-Qiong, Yuan, Xiang-Zhen, Li, Hai-Yan, Tan, Lan, Chen, Wei-An. 2018. Genome-wide association study identifies two loci influencing plasma neurofilament light levels. In BMC medical genomics, 11, 47. doi:10.1186/s12920-018-0364-8. https://pubmed.ncbi.nlm.nih.gov/29747637/
智鼠故事 
